Nicotine pouches are a newer class of smokeless products that don’t contain tobacco. Zyn became the first FDA-authorized brand on Jan. 16.
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
Schools have issued a stark warning to parents about highly addictive nicotine pouches being used by students.
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.
The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but will be "closely monitoring youth use.""The FDA's decision recognizes the role that Zyn can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products,
The U.S. Food and Drug Administration issued a rule to drastically reduce the amount of nicotine in cigarettes and other combusted tobacco products.
The proposal in the waning days of the Biden administration leaves it up to President-elect Donald Trump to finalize the effort — or scrap it.
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.
The FDA's proposed rule would slash nicotine levels in cigarettes, most cigars and other combustible tobacco products, but not vapes, hookahs or Zyn.
The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an extensive scientific review of them.
The Food and Drug Administration (FDA) released a sweeping proposal Wednesday to try to make cigarettes less addictive by lowering the amount of nicotine they contain, an eleventh-hour plan from